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Abstract
Background: Due to the steadily increasing number of cancer patients worldwide the early diagnosis and treatment
of cancer is a major field of research. The diagnosis of cancer is mostly performed by an experienced pathologist via
the visual inspection of histo-pathological stained tissue sections. To save valuable time, low quality cryosections are
frequently analyzed with diagnostic accuracies that are below those of high quality embedded tissue sections. Thus,
alternative means have to be found that enable for fast and accurate diagnosis as the basis of following clinical
decision making.
Methods: In this contribution we will show that the combination of the three label-free non-linear imaging
modalities CARS (coherent anti-Stokes Raman-scattering), TPEF (two-photon excited autofluorescence) and SHG
(second harmonic generation) yields information that can be translated into computational hematoxylin and eosin
(HE) images by multivariate statistics. Thereby, a computational HE stain is generated resulting in pseudo-HE overview
images that allow for identification of suspicious regions. The latter are analyzed further by Raman-spectroscopy
retrieving the tissue’s molecular fingerprint.
Results: The results suggest that the combination of non-linear multimodal imaging and Raman-spectroscopy
possesses the potential as a precise and fast tool in routine histopathology.
Conclusions: As the key advantage, both optical methods are non-invasive enabling for further pathological
investigations of the same tissue section, e.g. a direct comparison with the current pathological gold-standard.
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Background
The WHO expects the annual incidences of cancer to
almost double to 21.6 million by 2030 [1]. Evidently, an
early cancer diagnosis is the key factor for the survival
of patients. The diagnosis of cancer after initial suspicion
is complex and involves a number of elaborated diagnos-
tic approaches such as genomics and proteomics [2–4]. A
histopathological examination of the excised tissue is the
current gold-standard for deriving the final diagnosis [5].
In the majority of cases, the pathologist works with fix-
ated and embedded tissue samples. In order to save time,
also native frozen sections are evaluated as part of a quick
frozen section analysis. The analysis of frozen sections,
however, is challenging and sometimes deviates from the
results of an analysis of fixated and embedded sections
[5]. To overcome the current limitation of frozen section
diagnostics, new pathological tools are required allowing
for fast and accurate ex corpore in vivo diagnosis of malig-
nant transformed tissue. Thereby, the term ex corpore in
vivo refers to fresh biopsy tissue. Ideally, these techniques
are also applicable for in vivo investigations adding the
necessity to work non-invasive, i.e. preserving the tissue’s
integrity.
Within the last years the development and application
of optical methods for clinical pathology that potentially
meet these requirements has rapidly increased [5]. Among
these methods, spectroscopic imaging approaches are of
particular significance [6–9]. Ex vivo reflectance confo-
cal microscopy (CRM) was used to detect residuals of
non-melanoma skin cancer (NMSC) duringMoh’s surgery
[10]. Optical coherence tomography (OCT) demon-
strated its potential to differentiate between malignant
and benign tissue areas in head and neck, skin, genital
and bladder cancer [11]. The potential of photo acous-
tic imaging (PAI) for cancer diagnostics was evaluated
for melanoma [12] and breast cancer [13]. One-photon
excited autofluorescence (OPEF) was utilized to inves-
tigate fibrosarcoma, lung cancer and NMSC [14]. Lin-
ear Raman-microscopy was applied for differentiation of
healthy tissue from cancerous epithelium within human
skin, colon, brain and breast [15]. Further, various non-
linear microscopy methods were shown to enable for
detection of NMSC as well as head and neck, brain or
lung cancer [16]. However, most of these studies repre-
sent proof-of-concept studies and except of OCT these
methods have not been transferred into routine clini-
cal applications. The delay of technology transfer may
be attributed – among other reasons – to the increasing
complexity of state of the art cancer diagnostics reducing
physician’s available time to familiarize with new imaging
technologies as well as its image contrast and significance.
Thus, it is the task of scientists to reduce the complexity
of new technologies by translating the image information
into a format that physicians are accustomed to such as
hematoxylin and eosin (HE) stained images or by direct
prediction of the tissue’s malignancy state. Ideally, this
image translation is achieved entirely by computational
image analysis requiring no assistance of scientists or
physicians.
To automate such a translation of optical microscopy
data, the image contrast is required to provide cancer
specific information in the first place. Since the infor-
mation transferred by a single modality is limited, var-
ious optical methods are frequently combined such as
Raman-spectroscopy and OCT for skin cancer detection
[17]. These multimodal approaches can be grouped into
those that gather techniques with similar image acquisi-
tion times and experimental equipment and combinations
that merge sensitivity with specificity by coupling fast
imaging tools with techniques of high information density
per pixel. Here, we combine both multimodal concepts
to maximize the image acquisition speed and informa-
tion depth in order to improve the accuracy of image
translation and diagnostic results.
First, the fast non-linear microscopy methods CARS =
coherent anti-Stokes Raman-scattering, SHG = second
harmonic generation and TPEF = two-photon excited
autofluorescence were jointly applied to characterize
the architecture and biochemical composition of frozen
tissue sections. For the selection of regions of inter-
est (ROI), we demonstrate for the first time the pos-
sibility to derive computationally pseudo-HE images
from CARS/SHG/TPEF-images by applying multivariate
statistics. The pseudo-HE image can be analyzed by a
pathologist in the same manner as a normal HE image.
Following the selection of ROI based on pseudo-HE
images we applied Raman-spectroscopy for the prediction
of the diagnosis. Though compromised by its poor sensi-
tivity, Raman-spectroscopy is unprecedented for its high
specificity yielding information based on inherent molec-
ular vibrations that - like fingerprints - specifically charac-
terize chemical structures and biochemical compositions
of e.g. biological cells, tissues etc.
The non-invasiveness of non-linearmultimodal imaging
and Raman-spectroscopy enables for the direct compari-
sonwith the pathological gold standard requiring staining.
Thus, further analyses can be performed on the samples
pre-characterized by combining multimodal imaging and
Raman-spectroscopy. This new approach, the combina-
tion of non-linear multimodal images and Raman-spectra
of selected regions, was evaluated for ex vivo sections of
colon tissue that arose from p53 knockout mice [18]. The
mouse model was selected to investigate a single type
of tumor while minimizing the variance between indi-
viduals (mice). The results, therefore, allow for a reliable
estimation of the generalizability of the proposed optical
pathological tool with respect to the adenoma-carcinoma-
sequence and its diagnostic value.
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Methods
Sample preparation
Mice with an intestinal epithelial cell (IEC)-specific dele-
tion of the tumor suppressor gene p53 were received
by crossing of floxed p53 mice with villin-Cre mice
(Tp53IEC) [19]. As controls Tp53F/F mice were utilized.
These mice were treated intraperitoneally once a week
for 6 weeks with the carcinogen azoxymethane (AOM; 10
mg/kg). For histological and Raman-spectroscopic inves-
tigations mice were sacrificed at different time points after
the AOM application. The specific loss of p53 in the intes-
tine markedly enhances the carcinogen-induced tumor
incidence and leads to the development of invasive col-
orectal tumors beginning about 12 weeks after the first
AOM treatment.
Full preparation of colon and rectum was performed
for 47 individuals. Biopsies were acquired from 8 out of
these 47 individuals. Another cohort of 22 individuals
was divided into two groups of which biopsies were taken
in an alternating fashion every two weeks. In total, 69
individuals contributed to the complete training Raman-
dataset. For the present study, 6 individuals (2 males,
4 females) were selected randomly covering the whole
spectrum of diagnoses. In total 34 Raman-maps (46240
spectra) and the respective non-linear multimodal images
were acquired to investigate this reduced cohort.
Cryosections for the histo-pathological evaluation were
obtained following the standard procedure of washing the
specimens with phosphate buffered saline (PBS Buffer),
fixation using paraformaldehyde, embedding in paraffin
and cutting the sample in 10 μm slices which were stained
with hematoxylin and eosin (HE staining). For the Raman-
spectroscopic analysis, the specimens were washed with
PBS buffer and immediately frozen in liquid nitrogen.
Distilled water was used as embedding medium for the
cryosectioning step resulting in 20 μm thick slices. Thus,
a native sample - preserving the lipid distribution - is
obtained.
Brightfield images of the parallel HE stained as
well as Raman-spectroscopically examined sections were
recorded using a halogen illuminated Leica DM2500
microscope (Leica Microsystems, Wetzlar, Germany)
equipped with a Nikon Digital Sight (DS) camera system
using the DS-Fi1 CCD camera head (Nikon Instruments
Europe B.V., Germany). To superimpose the measured
Raman-maps with the their corresponding histopatholog-
ical assessment, all HE stained scan areas were imaged
using five different Leica objectives in the range of 1.25×
to 40× (1.25× HCX PL Fluotar (NA 0.04), 5× N Plan (NA
0.12), 10× N Plan (NA 0.25), 20× N Plan (NA 0.4), 40× N
Plan (NA 0.65)).
Non-linear multimodal microscopy
The experimental setup was presented elsewhere [20]. A
schematic of the experimental setup is displayed in Fig. 1.
Briefly, a Coherent Mira HP Titanium-Sapphire (Ti:Sa)
laser (Coherent, Santa Clara, USA) is pumped by a con-
tinuous wave Neodymium-Vanadate laser with an average
power of 18 W operating at 532 nm. The Ti:Sa-laser gen-
erates 2–3 ps pulses (FWHM) at 830 nm with a repetition
rate of 76 MHz. The 3.5 W averaged output power of the
Ti:Sa-laser is split into two parts. The first part is used
directly, i.e., without frequency conversion, as the Stokes
beam. The second part is coupled into an optical para-
metric oscillator (OPO, APE, Berlin, Germany) that allows
to adjust the pump wavelength in the range from 500 to
1600 nm. Tomatch the CH2 symmetrical stretching vibra-
tion at 2850 cm−1 for the CARS measurements, the OPO
is tuned to 671 nm. Both beams, pump and Stokes, are
temporally and spatially overlapped and coupled into a
laser scanning microscope (LSM 510 Meta, Zeiss, Jena,
Germany) and focused onto the sample with a 20× (NA
Fig. 1 Schematic of the experimental setup used for non-linear multimodal microscopy. 1 Ti:Sa-laser; 2 Optic parametric oscillator (OPO); 3 Rotating
mirror; 4 Photomultiplier (PMT); 5 Objective lens; 6 Condenser; 7 sample with superimposed grid outlining individual squares of the composite
multimodal image
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0.8) achromatic objective (Zeiss). The optical non-linear
response of the sample is wavelength filtered by means of
various dielectric filters and detected by photomultiplier
tubes (PMT, Hamamatsu Photonics, Hamamatsu, Japan)
in forward (CARS, SHG) and backward direction (TPEF).
Large area scans of the samples of up to 15×15 tile-scans,
each having a size of 450 μm × 450 μm, were recorded.
Every tile-scan was acquired with a resolution of 1,024 x
1,024 pixels and a pixel time of 1.6 μs. By averaging twice
the total acquisition the time per tile-scan does not exceed
16 s for all three modalities, i.e. CARS, TPEF and SHG.
Thus, the acquisition time for an image of 15× 15 squares
corresponding to a size of 6.75 mm × 6.75 mm is about
1 hour. The average power at the sample was 25 mW and
50 mW for the pump and Stokes beam, respectively. A
discussion about the applied power and potential linear
as well as non-linear tissue photo-damage can be found
elsewhere [21].
Linear Raman-microspectroscopy
Raman-spectra of 20 μm thick cryosections from colon
and rectum of mice as well as from biopsies on CaF2 slides
were recorded with an upright micro-Raman-setup (CRM
300, WITec GmbH, Ulm, Germany) equipped with a
300 g/mm grating (7 cm−1 resolution) and a Deep Deple-
tion CCD camera (DU401 BR-DD, ANDOR, 1024 × 127
pixels) cooled down to −65°C. The tissue Raman-spectra
were recorded with a 785 nm diode laser which was
focused through a Zeiss 50× objective (NA 0.7) onto the
sections. For the herein described study 34 Raman-scans
were recorded in scanning mode with a step size of 5 μm
and an integration time of 2 s per spectrum. The scan
dimensionwas chosen to be around 34×40 pixels (170μm
× 200 μm), so every scan consists of approximately 1360
Raman-spectra. As a standard for the subsequent pro-
cessing of the spectra a time series comprising 50 spectra
of 4-acetamidophenol was collected with an integration
time of 1 s per spectrum. Based on HE stained parallel
sections a trained pathologist selected the areas to bemea-
sured. Here we measured the Raman-spectra before the
multimodal images in order to check if burning effects
occurred. In the presented data set burning effects were
not observed.
Ethical approval
All animal studies were approved by the governmental
commission for animal protection (No. 02-007/13).
Results
Generation of pseudo-HE images out of CARS/TPEF/SHG
multimodal images
22 multimodal images were measured and the TPEF,
CARS and SHG channel were combined in false-colors.
Here we used green to represent TPEF, red for CARS and
SHG was coded in shades of blue. The images were pre-
treated separately: First the images were down-sampled
by a factor of 4. Then the uneven illumination of the
tile-scans was removed within the images and the con-
trast was adjusted (CARS:[0.05-0.015], TPEF:[0.05-0.04],
SHG:[0.001-0.001]) [22]. The resulting images are given
in Fig. 2 in row A. The workflow for pseudo-HE genera-
tion is sketched in Fig. 3. The pseudo-HE stained images
are generated using a partial least squares regression (PLS)
model with 3 components [23], which was trained with
one image (data not shown). PLS is a multivariate regres-
sion method that estimates the relationship between two
datasets and differs from traditional least squares regres-
sion in utilizing information of the independent and the
dependent variables. The RGB-values of an HE stained
image was modeled using the three color channels of
the multimodal image. Afterwards, regions with a certain
fingerprint of CARS, TPEF and SHG intensities were pre-
dicted to feature cell nuclei (dark violet) and thus this color
was added. This procedure was based on a linear discrim-
inant analysis model (LDA). The main idea of this classifi-
cation method is to find the optimal linear combination of
variables that maximizes the variations between different
classes and minimizes the variations within these classes.
This additional model was necessary as cell nuclei had
negative contrast in the multimodal images. The result
is referred to as computational HE stained or pseudo-
HE image. Its generation is performed automatically and,
therefore, allows for a fast screening. After the calculation
of the computational HE stain was performed, the back-
ground was determined and set to white. The background
was estimated by a sequence of steps. First the original
multimodal image (RGB) was segmented by k-means clus-
tering with k = 6. The pixels of the darkest class, i.e.
the class with the lowest value of sum over squared class
center, are considered as background contribution. Based
on this annotation a background mask was calculated. To
remove noise contributions in the segmentation result,
the estimated background mask was filtered by a median
filter. Thereafter morphological closing was applied to
fill gaps in the foreground and extending the foreground
area. Finally, the background mask was morphologically
opened in order to remove small foreground areas and
smooth the background edges (or specimen contour). The
resultingmaskwasmean filteredandusedasaweightingmask
allowing for a smooth removal of large background areas.
Spectral histopathology— statistical analysis of
Raman-spectra
The data preprocessing in case of the Raman-spectra and
statistical modeling were performed using the software
package R [24]. The packages used were ‘MASS’ [25], ‘pls’
[23], ‘KKNN’ [26] and ‘Peaks’ [27]. Several multivariate
statistical tools were applied, such as principal component
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Fig. 2 Overview of acquired and generated images of mouse colon sections (3 out of 22 images in total): In row A, multimodal images are displayed
(for details see Methods Section, non-linear multimodal microscopy). In row B and C the computationally derived pseudo-HE stained images based
on the multimodal images and the HE stained image are displayed, respectively. The pseudo-HE images of row B are generated non-invasively
allowing for a subsequent analysis by other modalities or stains. Red flag regions, which were subsequently analyzed by Raman-spectroscopy (see
Fig. 4) are marked with a white arrow in row A. The scale bar represents 500 μm
analysis (PCA), k-means and Weighted k-Nearest Neigh-
bors (KKNN), which shall be described briefly. For dimen-
sion reduction and data compression PCA is the most
popular and useful tool. The PCA transforms the vari-
ables of a dataset into a new set of variables that are linear
combinations of the former variables. The new values are
called principal components and are ranked according to
the variance contributions so that the first principal com-
ponent provides the highest data variance. Choosing only
the first few principal components allows a dimension
reduction with a marginal loss of information. K-means
is an unsupervised clustering method that arranges the
unlabeled dataset into a given number of groups (clus-
ters). It starts with a random distribution of cluster cen-
ters and iteratively moves them in order to minimize
the total within-cluster variance [28]. KKNN is a non-
parametric supervised classification method that is often
used because of its simplicity and good performance. To
assign a new observation, first the k observations in the
training dataset have to be found, which are closest to the
new observation. Then the new observation is classified
through the majority vote among the k neighbors. KKNN
- as an extension of k-Nearest Neighbors algorithm - also
takes into account the individual distances of the nearest
neighbors to the new observation in the form of weights
[26]. The performance of the classification was verified
through individual-out-cross-validation (IO-CV).
A standard spectral pre-treatment was applied [29].
First a background was subtracted using the SNIP algo-
rithm [30] followed by a vector normalization. The spec-
tra were projected on a PCA, minimizing the necessary
dimensions and computational time. The annotation of a
pathologist was transferred to a computer model by a k-
means-cluster-analysis with k ranging from 9–15 based on
the number of scans of one individual (mouse). The anno-
tation was performed in a blinded manner meaning that
the pathologist was not biased by the k-means-cluster-
analysis plots and utilized only the HE stained images
for diagnostics. Following the annotation, every Raman-
spectrum was linked to the pathologist’s diagnosis as the
major reason for measuring scans and not single Raman-
spectra. This procedure is called spectral histopathology
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Fig. 3 Schematic of the pseudo-HE image generation algorithm. CARS, TPEF and SHG images of the samples were acquired and combined into
multimodal images using a RGB color model. The multimodal images were preprocessed as follows. First, noise was removed by median filtering
and the images were down-sampled by a factor of 4. After that the uneven illumination of the single tile-scans was corrected and the contrast was
adjusted. For generation of the pseudo-HE stained images, a RGB color image and two masks were calculated. To convert a multimodal image into
RGB values of pseudo-HE image, a partial-least-square regression (PLS) method with 3 components was used which was trained with one image.
The mask of cell nuclei was predicted by a pre-trained LDA model and was used to color cell nuclei regions within the pseudo-HE stained image in
dark violet. Moreover, a background mask was estimated and used to color the background area of the pseudo-HE image in white
(SHP) and described elsewhere in full detail [31, 32].
The Weighted k-Nearest Neighbors (KKNN) model was
trained with one neighbor to be used for prediction and
the Minkowski distance in combination with the kernel
‘optimal’. The evaluation was done by an individual-out-
cross-validation. This approach incorporates the biolog-
ical variance in the performance estimation. Only with
such an approach a robust estimate of how the model
will perform in future applications, e.g. the generalization
performance of the model, can be derived. Shortly, the
Raman-spectra of one individual were excluded from the
model building and a classification model for the groups
‘adenoma’, ‘carcinoma’ and ‘normal’ was constructed. The
Raman-spectra of the individual currently excluded were
predicted using the classifier and the outcome was stored.
Accordingly, the Raman-spectra of all individuals were
once used as a test set. The result is put together in Table 1.
It should be noted that hyperplasia occured only once and
the corresponding region was excluded from the dataset.
Discussion
In this contribution we combined two optical imaging
approaches for a fast and precise pathological tissue
assessment. The first approach is used to generate
an unspecific overview. Therefore multimodal imaging
quickly generates large tissue images, which were trans-
lated into a pseudo-HE image for identification of suspi-
cious areas. These red flag areas were further analyzed
in more detail using Raman-spectroscopy to receive a
bio-spectroscopic fingerprint of these suspicious areas.
With the help of these fingerprints we were able to con-
struct a model for cancer diagnosis achieving a high
sensitivity.
Table 1 Individual-Out-Cross-Validation (IO-CV) of a KKNN
model; the model has a mean sensitivity of 100 % for the
classification between tumor and normal regions, but the mean
sensitivity drops to 80.16 % for a differential diagnosis, e.g. for the
classification task normal-adenoma-carcinoma
Annotated classes Characteristics
Predicted class Adenoma Carcinoma Normal Sensitivity / % Specificity / %
Adenoma 4 1 0 80 87.5
Carcinoma 3 5 0 62.5 95.2
Normal 0 0 16 100 100
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Multimodal imaging – an overview
The first step of the proposed diagnostic workflow (Fig. 3)
consisted of recording a multimodal image, which is uti-
lized to derive a pseudo-HE image by multivariate statis-
tics. For exemplification, the first row (A) in Fig. 2 displays
multimodal images of mouse colon sections (for sample
details see “Methods” Section, sample preparation). False-
colors code CARS in red, TPEF in green and SHG in
blue. CARS was adjusted to map the CH2-distribution
outlining mostly lipids, while the CARS signal originat-
ing from proteins is weaker as their molecular mass-
to-methylene group ratio is comparably decreased. The
TPEF signal was collected in the spectral range between
426–490 nm, thereby, highlighting the distribution of
strong auto-fluorophores such as elastin, NAD(P)H and
keratin, while SHG collected at 415 nm visualizes the
fibrous collagen network.
Proving the similarity of the information content of non-
linear multimodal and classical HE stained images, we
applied multivariate statistics in order to generate a com-
putational HE stain image out of the multimodal dataset.
The results are exemplified in row B of Fig. 2. For the
prediction of pseudo-HE images, we utilized a model
combining partial-least-square (PLS) regression with a
linear-discriminant-analysis (LDA) that was trained using
a single HE image. Subsequent to all multimodal mea-
surements, the samples were HE stained and imaged.
The corresponding HE images are depicted in row C of
Fig. 2. Apparently, morphological information are readily
retrieved from both set of images, i.e. in the pseudo-HE
images derived from the multimodal images (Fig. 2b) and
the real HE images (Fig. 2c). Some information, however,
is missing in the pseudo-HE images (Fig. 2b). In particular
the cell nuclei are at certain areas not optimally resolved
possibly due to signal intensity variations resulting in a
non-uniform brightness of the images. It shall be noted
that nuclei may be resolved in future pseudo-HE images
if stimulated Raman scattering at DNA specific Raman
resonances is applied featuring the required high signal-
to-noise ratio [33]. From Fig. 2b and c differences in the
color composition and brightness are visible. For exam-
ple, the submucosa appears darker within the pseudo-HE
images than in the corresponding HE images. Further
deviations result from the ethanol washing step during
the staining procedure removing soluble components.
Consequently, some soluble components were imaged
by non-linear multimodal microscopy but were removed
in advance to the acquisition of the HE images. The
advantage of the generated pseudo-HE images is that the
measurement is non-invasive, therefore allowing for fur-
ther analysis. Here, a HE stain was applied afterwards for
comparison, but the employment of other stains or mea-
surement modalities is also possible. Due to its speed and
non-invasiveness, the pseudo-HE stain can be applied in
a cryosection analysis setting or potentially even in-vivo.
Based on the pseudo-HE images a pathologist can identify
or define suspicious areas (red flags). These small red flag
areas can be further investigated by various approaches
like e.g. immunostains, or by other label-free spectro-
scopic techniques featuring a higher molecular sensitivity
than non-linear multimodal imaging. In this contribution
we applied Raman-spectroscopy as a second diagnos-
tic technique, offering molecular fingerprint information.
The results of the Raman-study are summarized in the
following section.
Raman-microspectroscopic imaging – diagnosis
As mentioned in the previous section certain areas (red
flags) were further characterized by means of Raman-
spectroscopy. These red flag regions are marked with a
white arrow in Figs. 2a and 4a. To prove whether Raman-
spectroscopy can be utilized as a molecular selective
diagnostic platform, the Raman-spectroscopically char-
acterized regions were annotated and diagnosed by an
experienced pathologist in a blinded manner. The adjec-
tive ’blinded’ means here that the multimodal images
and the Raman-spectroscopic generated image were
unknown to the pathologist. The test of the diagnostic
value of Raman-spectroscopy was achieved by application
of a recently reported workflow termed as spectral-histo-
pathology (SHP) [31, 32, 34]. In that approach every
Raman-scan is clustered and the diagnosis of the patholo-
gist is transferred to a computer model. Figure 4d displays
such a cluster-analysis. This cluster scan is subsequently
annotated using the groups displayed in Fig. 4e. Based
on this annotation mean Raman-spectra of different
regions can be derived. Figure 4f shows as an example
the mean Raman-spectrum of normal epithelial tissue.
Thereafter, a supervised classification can be applied in
order to discriminate between normal, adenoma and
carcinoma tissue. A hyperplastic area was only present
once in the data set, therefore the corresponding region
was excluded from further analysis. In the same manner
Raman-spectra of other morphologic areas (muscle,
connective tissue) or artefacts (background, spikes) were
excluded.
First, a univariate statistical test was applied to verify
whether the groups feature statistical significant differ-
ences. The statistical significance of the Raman-spectra
for the differentiation of tumor against normal tissue
and carcinoma against normal tissue were investigated by
applying a two-sample Wilcoxon test. The principal com-
ponent (PC) scores of the components 3, 4 and 5 were
proven to be significant for the task normal against tumor
tissue. The p-values were 0.001005, 0.019 and 0.003,
respectively. The scores of the fourth and fifth component
were significant for the task ’normal against carcinoma’
(p-value 0.027 and 0.00039). A boxplot of the scores of PC
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Fig. 4Workflow: aMultimodal image of a mouse colon section (for color code see Fig. 2); b Pseudo-HE stained image derived from the multimodal
image shown in a, c HE stained image of the same section as investigated in a, d a k-means-cluster-analysis (k = 9) of the Raman-measured region,
marked with a white arrow in a, e pathologist’s annotation; Here, normal epithelial tissue with non-epithelial components (other morphological
tissue types) and background contributions (left corner) are present; f pre-treated mean Raman-spectra of the region annotated as normal epithelial
tissue in e; the scale bar represents 500 μm. The colors within panel d were assigned arbitrary due to the k-means clustering, while the legend
applies only to panel e. The color selection in panel e is related to bio-medical information
3 is visualized in Fig. 5 together with the mean Raman-
spectra of the groups. The band assignment for interpret-
ing these Raman-spectra can be found in a number of
publications [35, 36]. Here, we assigned the bands for visu-
alization of the biggest differences and marked them in
Fig. 5. The band at 785 cm−1 can be attributed to the phos-
phate backbone vibration of DNA [35]. The other three
bands at 1003, 1449, 1657 cm−1 can be assigned to pro-
tein vibrations [35, 36]. The band at 1003 cm−1 originates
from the symmetric ring breathing of phenylalanine [35],
while the Raman-resonances at 1449 and 1657 cm−1 can
be attributed to the CH2 deformation vibration [36] and
Amide I vibration [35, 36], respectively.
The mean Raman-spectra were subsequently tested
for their diagnostic value. Therefore, the Raman-spectra
were pre-treated and a Weighted k-Nearest Neighbors
(KKNN) classifier was trained and evaluated. In order to
estimate the generalization performance of the classifier,
the biological variations between the different mice has
to be accounted for. To do so, we used an individual-
out-cross-validation scheme (IO-CV), where all Raman-
spectra of one individual were excluded from training
and then predicted. This procedure was iterated and the
result is shown in Table. 1. The confusion table shows
that the diagnosis of tumor regions, e.g. the classifi-
cation between tumor regions and normal regions, is
accomplished with 100 % mean sensitivity. The differen-
tial diagnosis, e.g. the discrimination between adenoma
and carcinoma regions, is also possible, but with a lower
sensitivity. Here, mis-classifications between adenoma
and carcinoma regions occurred. Nevertheless, the over-
all mean sensitivity for the differential diagnosis is 80.16 %
and may be increased in future experiments by improv-
ing the detection scheme using, e.g. shifted-excitation
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Fig. 5 The mean Raman-spectra of adenoma, carcinoma and normal tissue: The mean Raman-spectra corresponding to the classification system are
visualized. Selected peaks featuring large difference for distinct classes are marked by gray lines - see text for band assignment. In the upper left
corner a boxplot of PC 3 is given, which shows the highest significance (p= 0.001005) for the separation of normal and tumor tissue
Raman-difference-spectroscopy (SERDS) [37]. In a nut-
shell: the presented workflow allows for a robust and
objective diagnosis at least for tumorous and normal
epithelial tissue.
Conclusion
In the present study a combination of multimodal imag-
ing and Raman-microspectroscopy is suggested as a fast
and precise pathological screening tool. This combi-
nation of optical approaches bundles a fast overview
technique (multimodal imaging) for identification of sus-
picious regions (red flags) that are diagnosed by a highly
molecular sensitive but rather slow method (Raman-
spectroscopy). By applying multivariate statistical meth-
ods the multimodal images could be converted into
pseudo-HE stain images, which can be analyzed by a
pathologist in the same manner as normal HE images.
The comparison of pseudo-HE images derived from mul-
timodal images with real HE images proofs that both
HE staining and multimodal imaging (TPEF, SHG and
CARS) feature similar information. This pseudo-HE stain
image can be used by a pathologist to highlight suspi-
cious areas and mark them with red-flags. These red-flag
areas can be further analyzed with other techniques fea-
turing a higher sensitivity than non-linear multimodal
imaging. In this contribution, the slow but molecular
selective technique Raman-spectroscopy was tested for
a precise and robust diagnosis. Compared to a gold-
standard diagnosis of an experienced pathologist, the
Raman-based diagnostics featured 100 % mean sensitivity
for the prediction of normal and tumor tissue. The
differential diagnosis, the prediction of adenoma, car-
cinoma and normal epithelium, exhibits a mean sen-
sitivity of around 80 %. Thus, further improvement is
required if a differential diagnosis is desired. Never-
theless, the combination of multimodal imaging and
Raman-microspectroscopy as a fast, reliable tool to screen
large tissue areas and to diagnose normal epithelial tis-
sue from malignant tissue (adenoma, carcinoma) could
be demonstrated.
The presented combination of multimodal imaging and
Raman spectroscopy can support a pathologist especially
in a setting where the preparation of high quality fix-
ated and embedded tissue sections is hardly possible, like
for an intraoperative cryosection analysis. As both optical
imaging methods are non-invasive, a subsequent staining
with conventional HE stain remains feasible, allowing for
a direct comparison with the current pathological gold-
standard or other stains and methods. The non-invasive
character of the methodology introduced within this arti-
cle also allows for further in-vivo applications. The tech-
nical transformation of the combination of multimodal
imaging and Raman-spectroscopy into an operation the-
ater for in-vivo studies during an operation is possible and
subject to current efforts of us. Such an in-vivo applica-
tion would increase the possibilities of cancer diagnosis
and treatment, since an online-monitoring of certain areas
can be performed.
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